Company intelligence / Profile preview

Allevi

Philadelphia, Pennsylvania, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Allevi's platform enables researchers to design, print, and engineer 3D tissues and biofabricated constructs, accelerating cutting-edge biomedical research in organ-on-a-chip, disease models, tissue engineering, and drug screening. No clinical pipeline or therapeutic candidates; usage is by academic and industry research labs.

Modalities: Device (desktop 3D bioprinters for biofabrication)Hydrogel-based drug delivery therapy (supports printing hydrogels)Cell therapy (enables printing tissues with living cells)Biologic (used to print with cells and biomaterials)
Industry: Non-Drug Biotech

Partnerships

Hundreds of academic and industry labs globally (no specific pharma/biotech partnerships disclosed)

Beyond the preview

Go deeper on Allevi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allevi.

Explore the full profile